BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38340647)

  • 1. Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
    Dinicu AI; Dioun S; Wang Y; Huang Y; Wright JD; Tergas AI
    Gynecol Oncol; 2024 May; 184():214-223. PubMed ID: 38340647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
    Uppal S; Chapman C; Spencer RJ; Jolly S; Maturen K; Rauh-Hain JA; delCarmen MG; Rice LW
    Obstet Gynecol; 2017 Feb; 129(2):295-304. PubMed ID: 28079775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States.
    Dinicu AI; Dioun S; Goldberg M; Crookes DM; Wang Y; Tergas AI
    Cancer Med; 2023 Dec; 12(23):21452-21464. PubMed ID: 37964735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
    Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
    Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
    [No Abstract]   [Full Text] [Related]  

  • 6. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
    Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
    Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
    Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
    Suk R; Hong YR; Rajan SS; Xie Z; Zhu Y; Spencer JC
    JAMA Netw Open; 2022 Jan; 5(1):e2143582. PubMed ID: 35040970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Inequities in Cervical Cancer Quality of Care and Survival Related to Ethnicity and Socioeconomic Factors.
    Cantwell CJ; Moroney MR; Sheeder J; Guntupalli SR
    J Low Genit Tract Dis; 2021 Jul; 25(3):205-209. PubMed ID: 34050109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non-Small-Cell Lung Cancer in the United States.
    Dee EC; Swami N; Kazzi B; Lapen K; Franco I; Jain B; Patel TA; Mahal BA; Rimner A; Wu A; Iyengar P; Li B; Florez N; Gomez DR
    JCO Oncol Pract; 2024 Apr; 20(4):525-537. PubMed ID: 38252900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
    Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Access to Radiotherapy Among Hispanic/Latinx Populations in the United States: How Far Have We Left to Go?
    Verdini NP; Santos PMG; Vicioso-Mora YM; Rivera A; Perez CA; McClelland S
    Am J Clin Oncol; 2024 Jan; 47(1):40-47. PubMed ID: 37880834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
    Kucera CW; Chappell NP; Tian C; Richardson MT; Tarney CM; Hamilton CA; Chan JK; Kapp DS; Leath CA; Casablanca Y; Rojas C; Sitler CA; Wenzel L; Klopp A; Jones NL; Rocconi RP; Farley JH; O'Connor TD; Shriver CD; Bateman NW; Conrads TP; Phippen NT; Maxwell GL; Darcy KM
    Gynecol Oncol; 2024 May; 184():224-235. PubMed ID: 38340648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
    Ramey SJ; Asher D; Kwon D; Ahmed AA; Wolfson AH; Yechieli R; Portelance L
    Gynecol Oncol; 2018 Apr; 149(1):53-62. PubMed ID: 29605051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
    Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States.
    Nogueira LM; May FP; Yabroff KR; Siegel RL
    J Clin Oncol; 2024 Apr; 42(12):1368-1377. PubMed ID: 37939323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
    Bruce SF; Joshi TV; Chervoneva I; Yi M; Chatterjee-Paer S; Burton ER; Edelson MI; Sorosky JI; Shahin MS
    Obstet Gynecol; 2019 Sep; 134(3):559-569. PubMed ID: 31403593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States.
    Howard JM; Nandy K; Woldu SL; Margulis V
    JAMA Netw Open; 2021 Jun; 4(6):e2112813. PubMed ID: 34106265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.